New York, USA– January, 10, 2023. Vertic is now part of the Globant family of companies, and we couldn’t be prouder!
Twenty years ago, Vertic founders Sebastian Jespersen and Mads Petersen had a goal to help leading companies become more relevant, while striving to be a first-class digital agency. Today, with Globant (NYSE: GLOB), a digitally native company that helps organizations reinvent themselves and unleash their potential, Vertic has an opportunity of world class proportions.
It is no longer enough for a digital ad agency to formulate strategies and design an interface. Clients increasingly request deep technological resources and ongoing campaign execution skills—so we can help them deliver on the kind of entanglement that creates Share of Life. Globant is a leading force in the IT and software development space, and they will enable Vertic to better deliver on client promises as we expand our expertise.
This move is genuinely transformational. We are truly excited about the synergies between Vertic and Globant, a company that not only represents a natural home for our work but has the global vision to support a new view of digital marketing’s expanding capabilities.
Globant is a digitally native company that helps organizations reinvent themselves and unleash their potential. They are the place where innovation, design and engineering meet scale.
For more information, visit www.globant.com.
Vertic is an independent global digital agency helping F500 companies with their digital transformation journey and is home to the Share of Life® philosophy. Through Share of Life™, Vertic utilizes strategy, insights, design and technology to help brands form deeper and lasting connections with their customers.
For more information, visit www.vertic.com/who-we-are.
Mastering digital engagement at medical congress booths: Explore strategic and tactical principles for personalized visitor experiences, immersive technologies, and effective audience connections.
Opportunities and challenges as regards marketing of an establish product in pharma